Image via Wikipedia
It’s a doctor’s dream — an unlimited supply of disease-free blood.
And it may not be the stuff of fiction for long, reports CBS News correspondent Elizabeth Palmer.
Someone in the United States needs blood every two seconds. In surgery, on cancer words, on the nation’s battlefields — blood transfusions save lives.
But in the U.S., demand often exceeds supply. And elsewhere, especially in the developing world, there’s a real chance the blood cud be contaminated with diseases such as AIDS or Hepatitis C.
Enter Dr. Marc Turner, a cell biologist from Scotland who received a multi-million dollar research grant to
Image via Wikipedia
A University of Bristol team extracted stem cells from the veins, then used them to stimulate new blood vessel growth in mice, Circulation reports.
The researchers say their findings could bring treatments to repair damaged heart muscle one step closer.
However, a stem cell expert warned that they remained some years away.
Stem cells are attractive to medical researchers because they have the ability to produce many different types of human cell, opening up the possibility of repair or renewal for tissues ravaged by disease or injury (…)
In 2010, L V Prasad Eye Institute (LVPEI) moved away from culturing corneal stem cells in a petri-dish in the laboratory to directly culturing and expanding them on the patient’s eye.
This ingenuous technique was termed Simple Limbal Epithelial Transplantation (SLET) to contrast it from the radical tissue transplants and complex culture techniques that were the standard of care at that time.
SLET completely eliminates the need for laboratory based processing thereby making it possible to be executed by any well trained surgeon anywhere (…)
A pilot clinical trial was done on a small sample size including 125 patients, 65 adults and 60
A two-year-old Delhi boy suffering from thalassemia got a new lease of life after a Bangalorean donated his blood stem cells to him. This is the first reported case in India of a thalassemia patient receiving blood stem cells from an unrelated donor.
Garvit Goel was advised to go for a blood stem cell transplant a year ago. None of his family members qualified to be potential donors. That’s when Sumeet Mahjan, a software professional from MindTree, stepped in.
For Sumeet, the turning point came in 2011 when his colleague’s 11-year-old son was diagnosed with leukemia. MindTree requested Datri, an NGO
World stem cell leaders will converge on Promega’s BioPharmaceutical
Technology Center in Fitchburg, Wisconsin, on April 30 for the 9th
Annual Wisconsin Stem Cell Symposium: From Stem Cells to Blood.
Coordinated by the nonprofit BioPharmaceutical Technology Center Institute, the University of Wisconsin-Madison Stem Cell and Regenerative Medicine Center
and the UW-Madison Blood Research Program, this year’s symposium is
focused on how the stem cells that give rise to blood develop and
It will also look at the diversity of insights stem cell
studies have provided other fields.
Highlighted topics include genesis and regulation of progenitor cells
and hematopoietic stem cells, stem cell genomes/epigenomes, stem cell
microenvironment, and tumor initiating